Thus, one could argue that persons with SCI at or distal to T5 who are overweight/obese may warrant more aggressive clinical monitoring and, if indicated, initiation of pharmacological or rehabilitation intervention(s) to increase the level of activity and, if possible, reduce adiposity in an effort to maintain peripheral insulin sensitivity and thus improve the lipid profile and associated risk of cardiovascular disease. The gene discussed is INS; the disease is cardiovascular disorder.